#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on the Effectiveness of Venetoclax and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Poland

  • Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia Denmark France Germany +7

  • Study of Belimumab with Rituximab and Venetoclax for Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study Comparing Venetoclax and Obinutuzumab with Drug Combination for Fit Patients with Untreated Chronic Lymphocytic Leukemia Without Specific Genetic Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy Spain

  • Study on Ibrutinib and Venetoclax for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Ibrutinib for Patients with Chronic Lymphocytic Leukemia and TP53 Mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia France Hungary Italy Poland Spain +1

  • Study on Venetoclax, Ibrutinib, and Obinutuzumab for Chronic Lymphocytic Leukemia Patients Not in Complete Remission or with Detectable Bone Marrow Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark The Netherlands